The aim of the study was to evaluate the role of ultrasound guided fine needle aspiration cytology (FNAC) in the restaging of node positive breast cancer after neoadjuvant chemotherapy (NAC). From January 2016 – October 2018, 90 node positive stage IIA-IIIC breast cancer cases undergoing NAC were included in the study. The largest, most superficial and the most caudal axillary node metastasis confirmed by fine needle aspiration cytology (FNAC) was marked with clip. After NAC, restaging of axilla was performed with ultrasound and FNAC of the marked and/or the most suspicious axillary node. Of the 90 cases, 58 with available ultrasound guided percutaneous needle biopsy data were further evaluated. Axilla conserving surgery was performed in 37 of 58 cases and axillary lymph node dissection (ALND) in 21 of 58 cases. False Positive Rate (FPR) of FNAC after NAC was 12%, False Negative Rate (FNR) — 58%, sensitivity — 54%, specificity — 82%, accuracy 62%. FNAC after NAC had low FPR and was found to be useful in predicting residual axillary disease and to streamline surgical decision making regarding ALND. However, FNR was unacceptably high and FNAC alone was not able to predict ypCR and omission of further axillary surgery.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Akay C. L. Albarracin C. Torstenson T. Bassett R. Mittendorf E. A. Yi M. Kuerer H. M. Babiera G. V. Bedrosian I. Hunt K. K. Hwang R. F. (2018). Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J.24 (1) 28–34.
Baumgartner A. Tausch C. Hosch S. Papassotiropoulos B. Varga Z. Rageth C. Baege A. (2018). Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast39 19–23.
Boughey J. C. Ballman K. V. Hunt K. K. McCall L. M. Mittendorf E. A. Ahrendt G. M. Wilke L. G. Le-Petross H. T. (2015). Axillary ultra-sound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: Results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J. Clin. Oncol.33 (30) 3386–3393.
Boughey J. C. McCall L. M. Ballman K. V. Mittendorf E. A. Ahrendt G. M. Wilke L. G. Taback B Leitch AM Flippo-Morton T Hunt K. K. (2014). Tumor biology correlates with rates of breastconserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial. Ann. Surg.260 608–616.
Caudle A. S. Yang W. T. Krishnamurthy S. Mittendorf E. A. Black D. M. Gilcrease M. Z. et al. (2016). Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection. J. Amer. Soc. Clin. Oncol.34 (10) 1072–1078.
Ciatto S. Brancato B. Risso G. Ambrogetti D. Bulgaresi P. Maddau C. … Houssami N. (2007). Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res. Treat.103 (1) 85–91.
Cools-Lartigue J. Meterissian S. (2012). Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: A review. World J. Surg.36 (1) 46–54.
Diego E. J. McAuliffe P. F. Soran A. McGuire K. P. Johnson R. R. Bonaventura M. Ahrendt G. M. (2016). Axillary staging after neoadjuvant chemotherapy for breast cancer: A pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes. Ann. Surg. Oncol.23 (5) 1549–1553.
Dominici L. S. Negron Gonzalez V. M. Buzdar A. U. Lucci A. Mittendorf E. A. Le-Petross H. T. Babiera G. V. Meric-Bernstam F. Hunt K. K. Kuerer H. M. (2010). Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemo-therapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer116 (12) 2884–2889.
Gipponi M. Fregatti P. Garlaschi A. Murelli F. Margarino C. Depaoli F. Baccini P. Gallo M. Friedman D. (2016). Axillary ultrasound and Fine-Needle Aspiration Cytology in the preoperative staging of axillary node metastasis in breast cancer patients. Breast30 146–150.
Hieken T. J. Trull B. C. Boughey J. C. Jones K. N. Reynolds C. A. Shah S. S. Glazebrook K. N. (2013). Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. Surgery154 (4) 831–840.
Johnson J. Barmparas G. Chung A. Giuliano A. Amersi F. (2016). Predictors of complete response to neoadjuvant chemotherapy in breast cancer. Ann. Surg. Oncol.23 (3) 378–379.
Koolen B. B. Donker M. Straver M. E. van der Noordaa M. E. M. Rutgers E. J. T. Valdés Olmos R. A. Vrancken Peeters M. J. T. F. D. (2017). Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy. Brit. J. Surg.104 (9) 1188–1196.
Koolen B. B. Pengel K. E. Wesseling J. Vogel W. V. Vrancken Peeters M. J. T. F. D. Vincent A. D. Gilhuijs KG Rodenhuis S Rutgers EJ Valdés Olmos R. A. (2014). Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy. Eur. J. Nucl. Med. Mol. Imaging41 (1) 32–40.
Le-Petross H. T. McCall L. M. Hunt K. K. Mittendorf E. A. Ahrendt G. M. Wilke L. G. Ballman K. V. Boughey J. C. (2018). Axillary ultra-sound identifies residual nodal disease after chemotherapy: Results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). Amer. J. Roentgeno.210 (3) 669–676.
Loibl S. Volz C. Mau C. Blohmer J. U. Costa S. D. Eidtmann H. et al. (2014). Response and prognosis after neoadjuvant chemotherapy in 1051 patients with infiltrating lobular breast carcinoma. Breast Cancer Res. Treatment144 (1) 153–162.
Nakamura R. Yamamoto N. Miyaki T. Itami M. Shina N. Ohtsuka M. (2018). Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer. Breast Cancer25 (1) 86–93.
Pesek S. E. King H. M. Koelliker S. Raker C. Edmonson D. Dizon D. S. Gass J. (2017). Axillary ultrasound fine needle aspiration biopsy: Is there a role in the post Z-0011 era? Amer. J. Clin. Oncol.41 (7) 702–707.
Puzāka B. Irmejs A. (2016). Paduses operācijas apjoms krūts vēža slimniecēm pēc neoadjuvantas ķīmijterapijas. Rīgas Stradiņa universitāte 2016. gada Zinātniskā konference Rīgā 2016. Tēzes 207. lpp. [RSU Scientific Conference. Abstract Book 2016]. Available from: https://www.rsu.lv/sites/default/files/imce/Zinātnesdepartaments/2016/Vsekcija/paduses_operacijas_apjoms_kruts_vezis.pdf (accessed 15.05.2019).
Rao R. Lilley L. Andrews V. Radford L. Ulissey M. (2009). Axillary staging by percutaneous biopsy: Sensitivity of fine-needle aspiration versus core needle biopsy. Ann. Surg.Oncol.16 (5) 1170–1175.
Vidya R. Bickley B. (2017). Pre-operative axillary staging: Should core biopsy be preferred to fine needle aspiration cytology? Ecancermedical-science11 724.
Vijayaraghavan G. R. Vedantham S. Kataoka M. DeBenedectis C. Quinlan R. M. (2017). The relevance of ultrasound imaging of suspicious axillary lymph nodes and fine-needle aspiration biopsy in the post-ACOSOG Z11 era in early breast cancer. Acad. Radiol.24 (3) 308–315.
Vugts G. Maaskant-Braat A. J. G. de Roos W. K. Voogd A. C. Nieuwenhuijzen G. A. P. (2016). Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands. Eur. J. Surg. Oncol.42 (7) 956–964.
You S. Kang D. K. Jung Y. S. An Y.-S. Jeon G. S. Kim T. H. (2015). Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound MRI and 18F-FDG PET/CT. Brit. J. Radiol.88 (1052) 20150143.
Zhang F. Zhang J. Meng Q.-X. Zhang X. (2018). Ultrasound combined with fine needle aspiration cytology for the assessment of axillary lymph nodes in patients with early stage breast cancer. Medicine97 (7) e9855.